# US 2016/0355460 A1 · Preparation of 18F-FLUCICLOVINE

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355460 A1
- Document ID: US20160355460A1
- Status: Published application
- Kind: A1
- Application number: 15/173,839
- Filed: 2016-06-06
- Published: 2016-12-08
- Earliest claimed: 2012-08-09
- Assignees: Ge Healthcare Limited
- Applicants: GE Healthcare Limited
- Inventors: Anders Svadberg; Olav Ryan; Roger Smeets
- Web page: https://patentgrep.com/patent/US20160355460A1

## CPC

- C07C 227/40: Separation; Purification
- A61K 51/0406: {Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines}
- B01J 16/00: Chemical processes in general for reacting liquids with non- particulate solids, e.g. sheet material; Apparatus specially adapted therefor (B01J19/08 takes precedence)
- B01J 19/24: Stationary reactors without moving elements inside (B01J19/08, B01J19/26 take precedence; with stationary particles B01J8/02)
- B01J 19/245: {placed in series}
- B01J 19/248: {Reactors comprising multiple separated flow channels}
- C07B 59/001: {Acyclic or carbocyclic compounds}
- C07C 227/16: by reactions not involving the amino or carboxyl groups
- C07C 227/18: by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C 227/20: by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
- C07C 269/06: by reactions not involving the formation of carbamate groups
- G21G 1/10: by bombardment with electrically charged particles (irradiation devices G21K5/00)
- B01J 2219/24: Stationary reactors without moving elements inside
- B01J 2219/2401: Reactors comprising multiple separate flow channels
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C07B 2200/09: Geometrical isomers
- C07C 2601/04: with a four-membered ring
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- G21G: CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES (applications of radiation in general G21H5/00; handling particles, e.g. neutrons, or electromagnetic radiation not otherwise provided for G21K)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present invention provides a method for the production of [18F]-FACBC which has advantages over know such methods. Also provided by the present invention is a system to carry out the method of the invention and a cassette suitable for carrying out the method of the invention on an automated radiosynthesis apparatus.

## Claims

### Claim 1

1) A system for carrying out a method to prepare 1-amino-3-[18F]-fluorocyclobutanecarboxylic acid ([18F]-FACBC) comprising:
(a) a solid phase having compound of Formula II adsorbed on its surface
wherein:
PG1 is a carboxy protecting group; and,
PG2 is an amine protecting group;
(b) a source of PG1 deprotecting agent to be reacted with said compound of Formula II;
(c) a source of elution solution to be passed through said solid phase to obtain an eluted compound of Formula III:
(d) a source of PG2 deprotecting agent to be reacted with said compound of Formula III to obtain a reaction mixture comprising [18F]-FACBC;
(e) a reaction container; and,
(f) a waste means;
wherein said system further comprises means permitting sequential flow from:
(i) (e) to (a);
(ii) (b) to (a);
(iii) (a) to (f);
(iv) (c) to (e) via (a); and,
(v) (d) to (e).

### Claim 2 (depends on 1)

2) system as defined in claim 1 wherein said compound of Formula II is a compound of Formula IIa:
wherein PG1 and PG2 are as defined in claim 1.

### Claim 3 (depends on 1)

3) system as defined in claim 1 wherein PG1 is ethyl.

### Claim 4 (depends on 1)

4) system as defined in claim 1 wherein PG2 is t-butoxycarbonyl.

### Claim 5 (depends on 1)

5) system as defined in claim 1 wherein said solid phase is a tC18 solid phase extraction (SPE) column.

### Claim 6 (depends on 1)

6) system as defined in claim 1 wherein said PG1 deprotecting agent is NaOH.

### Claim 7 (depends on 1)

7) system as defined in claim 1 wherein said PG2 deprotecting agent is HCl.

### Claim 8 (depends on 1)

8) system as defined in claim 1 wherein said elution solution is water.

### Claim 9 (depends on 1)

9) A system for carrying out said method to prepare 1-amino-3-[18F]-fluorocyclobutanecarboxylic acid ([18F]-FACBC) comprising the system as defined in claim 1 and further comprising:
(g) a source of a precursor compound of Formula I
wherein:
LG is a leaving group;
PG1 as defined in claim 1; and,
PG2 is as defined in claim 1; and,
(h) a source of [18F]fluoride.

### Claim 10 (depends on 1, 9)

10) The system as defined in claim 9 wherein said compound of Formula I is a compound of Formula Ia:
wherein LG is as defined in claim 9, PG1 is as defined in claim 1, and PG2 is as defined in claim 1.

### Claim 11 (depends on 9)

11) The system as defined in claim 9 wherein LG is trifluoromethanesulfonate.

### Claim 12 (depends on 1)

12) The system as defined in claim 1 further comprising a hydrophilic lipophilic balanced (HLB) solid phase to purify said 1-amino-3-[18F]-fluorocyclobutanecarboxylic acid.

### Claim 13 (depends on 12)

13) The system as defined in claim 12 further comprising a second purification means comprising an alumina solid phase.

### Claim 14 (depends on 12)

14) A cassette comprising the system as defined in claim 12 for use on an automated synthesis apparatus.

### Claim 15 (depends on 1)

15) A cassette comprising the system as defined in claim 1 for use on an automated synthesis apparatus.

### Claim 16 (depends on 13)

16) A cassette comprising the system as defined in claim 13 for use on an automated synthesis apparatus.

### Claim 17 (depends on 1)

17) The system as defined in claim 1 wherein said system is suitable for use with an automated radiosynthesis apparatus.
